Akebia Therapeutics | AKBA - Market Capitalization


Akebia Therapeutics reported $192.3M in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 4.53B 199M Aug/2026
Akebia Therapeutics USD 427M 297M Dec/2025
Alnylam Pharmaceuticals USD 40.19B 3.96B Jun/2026
Amgen USD 209.65B 14.21B Aug/2026
Ardelyx USD 1.48B 63M Mar/2026
Astellas Pharma JPY 4.1T 160.64B Aug/2026
AstraZeneca USD 178.16B 111.83B Aug/2026
Bayer EUR 48.39B 834.21M Aug/2026
BioMarin Pharmaceutical USD 11.71B 651M Aug/2026
Cspc Pharmaceutical CNY 99.86B 3.93B Aug/2026
Deva Holding AS TRY 17.54B 7.76B Sep/2023
Dianthus Therapeutics USD 4.58B 2.8B Mar/2026
Exelixis USD 15.27B 1.73B Aug/2026
Fresenius Medical Care EUR 12.42B 1.87B Aug/2026
GlaxoSmithKline GBP 80.14B 3.66B Jun/2026
Ionis Pharmaceuticals USD 13.1B 642M Jun/2026
J&J USD 611.36B 32.21B Jun/2026
Kangmei Pharma CNY 24.48B 3.45B Mar/2026
Karyopharm Therapeutics USD 221M 95M Aug/2026
Laboratorios Farma EUR 4.17B 917.16M Mar/2026
Lexicon Pharmaceuticals USD 418M 73M Dec/2025
Malin Corporation EUR 133.52M 29.05M Aug/2026
Medical Developments International AUD 37.11M 25.41M Aug/2026
Nektar Therapeutics USD 12.98B 10.86B Aug/2026
Neuren Pharmaceuticals AUD 2.44B 80.57M Aug/2026
Organigram Holdings CAD 252.47M 59.69M Mar/2026
Ovoca Bio EUR 5.1M 3.93M Aug/2026
Pharma Mar EUR 1.39B 78.26M Aug/2026
Prothena USD 516M 2M Mar/2026
Qiagen NV USD 8.47B 396.81M Aug/2026
Regeneron Pharmaceuticals USD 65.37B 16.31B Jun/2026
Roche Holding CHF 270B 3.66B Jun/2026
Sanofi EUR 91.15B 9.12B Jun/2026
Sarepta Therapeutics USD 1.5B 402M Aug/2026
Sartorius EUR 15.63B 1.38B Jun/2026
Tectonic Therapeutic USD 580M 190M Mar/2026
Vanda Pharmaceuticals USD 279M 6M Dec/2024
Zealand Pharma A/S 33.35B 12.51B Aug/2026